The DOI matches its Crossref record; 617 of the 617 references it cites were found in a registry or an index.
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Open accessAbstract
BACKGROUND: Intermediate hyperglycaemia (IH) is characterised by one or more measurements of elevated blood glucose concentrations, such as impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and elevated glycosylated haemoglobin A1c (HbA1c). These levels are higher than normal but below the diagnostic threshold for type 2 diabetes mellitus (T2DM). The reduced threshold of 5.6 mmol/L (100 mg/dL) fasting plasma glucose (FPG) for defining IFG, introduced by the American Diabetes Association (ADA) in 2003, substantially increased the prevalence of IFG. Likewise, the lowering of the HbA1c threshold from 6.0% to 5.7% by the ADA in 2010 could potentially have significant medical, public health and socioeconomic impacts. OBJECTIVES: To assess the overall prognosis of people with IH for developing T2DM, regression from IH to normoglycaemia and the difference in T2DM incidence in people with IH versus people with normoglycaemia. SEARCH METHODS: We searched MEDLINE, Embase, ClincialTrials.gov and the International Clinical Trials Registry Platform (ICTRP) Search Portal up to December 2016 and updated the MEDLINE search in February 2018. We used several complementary search methods in addition to a Boolean search based on analytical text mining. SELECTION CRITERIA: We included prospective cohort studies investigating the development of T2DM in people with IH. We used standard definitions of IH as described by the ADA or World Health Organization (WHO). We excluded intervention trials and studies on cohorts with additional comorbidities at baseline, studies with missing data on the transition from IH to T2DM, and studies where T2DM incidence was evaluated by documents or self-report only. DATA COLLECTION AND ANALYSIS: One review author extracted study characteristics, and a second author checked the extracted data. We used a tailored version of the Quality In Prognosis Studies (QUIPS) tool for assessing risk of bias. We pooled incidence and incidence rate ratios (IRR) using a random-effects model to account for between-study heterogeneity. To meta-analyse incidence data, we used a method for pooling proportions. For hazard ratios (HR) and odds ratios (OR) of IH versus normoglycaemia, reported with 95% confidence intervals (CI), we obtained standard errors from these CIs and performed random-effects meta-analyses using the generic inverse-variance method. We used multivariable HRs and the model with the greatest number of covariates. We evaluated the certainty of the evidence with an adapted version of the GRADE framework. MAIN RESULTS: : HR 10.10 (95% CI 3.59 to 28.43), 6 studies, 4532 participants. In subgroup analyses, there was no clear pattern of differences between geographic regions. We downgraded the evidence for the prognostic effect of IH versus normoglycaemia to low-certainty evidence due to study limitations because many studies did not adequately adjust for confounders. Imprecision and inconsistency required further downgrading due to wide 95% CIs and wide 95% prediction intervals (sometimes ranging from negative to positive prognostic factor to outcome associations), respectively.This evidence is up to date as of 26 February 2018. AUTHORS' CONCLUSIONS: Overall prognosis of people with IH worsened over time. T2DM cumulative incidence generally increased over the course of follow-up but varied with IH definition. Regression from IH to normoglycaemia decreased over time but was observed even after 11 years of follow-up. The risk of developing T2DM when comparing IH with normoglycaemia at baseline varied by IH definition. Taking into consideration the uncertainty of the available evidence, as well as the fluctuating stages of normoglycaemia, IH and T2DM, which may transition from one stage to another in both directions even after years of follow-up, practitioners should be careful about the potential implications of any active intervention for people 'diagnosed' with IH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–617 of 617
Wie häufig ist Typ-2-Diabetes in Deutschland?
Rathmann, W., & Meisinger, C. (2010) · Der Diabetologe · doi:10.1007/s11428-009-0496-8 · Cited by 5
A natural history of impaired glucose tolerance in North Jordan
Ammari, F. F., Batieha, A. M., Jaddou, P., Okashi, M., & Ajlouni, K. M. (1998) · Practical Diabetes · doi:10.1002/pdi.1960150505 · Cited by 5
Li, C., Tsai, S., & Chou, P. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.11.023 · Cited by 5
Glucemia basal alterada y riesgo de diabetes mellitus a los 10 años. Estudio de cohorte
Baena-Díez, J. M., Bermúdez-Chillida, N., Mundet, X., et al. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2010.05.033 · Cited by 5
Zhang, T., Li, Y., Zhang, H., Sun, D., Li, S., Fernandez, C., Harville, E. W., Bazzano, L., He, J., & Chen, W. (2016) · Endocrine · doi:10.1007/s12020-016-0948-z · Cited by 5
Trend analysis of diabetic prevalence and incidence in a rural area of South Korea between 2003–2008
Jeong, J. Y., Kim, J., Kim, B., Moon, S. S., Kim, H., Park, K., Won, K. C., Lee, H. W., Yoon, J. S., Shon, H., et al. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00045.x · Cited by 4
Kato, M., Takahashi, Y., Matsushita, Y., Mizoue, T., Inoue, M., Kadowaki, T., Tsugane, S., & Noda, M. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00119.x · Cited by 4
Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study
Wilson, P. W. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1068 · Cited by 4
Costa, B., Vizcaíno, J., Piñol, J. L., Martín‐Luján, F., Cabré, J. J., & Basora, J. (2005) · Atención Primaria · doi:10.1157/13071917 · Cited by 4
Yang, H. K., Ha, H., Rhee, M., Lee, J., Park, Y., Kwon, H., Yim, H., Kang, M., Lee, W., Son, H., et al. (2016) · Medicine · doi:10.1097/md.0000000000003053 · Cited by 4
Amini, M., & Janghorbani, M. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.02.005 · Cited by 3
Gale, E. A. (2013) · Heart · doi:10.1136/heartjnl-2012-302763 · Cited by 3
Hr, A. M., & Azizi, F. (2009) · Journal of Diabetes & Metabolic Disorders · Cited by 2
Mirbolouk, M., Hajebrahimi, M. A., Akbarpour, S., Tohidi, M., Azizi, F., & Hadaegh, F. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12633 · Cited by 2
Sharifi, F., Jaberi, Y., Mirzamohammadi, F., Mirzamohammadi, H., & Mousavinasab, N. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117240 · Cited by 2
Oizumi, T., Daimon, M., Karasawa, S., Kaino, W., Takase, K., Jimbu, Y., Wada, K., Kameda, W., Susa, S., & Kato, T. (2011) · Diabetology International · doi:10.1007/s13340-011-0021-3 · Cited by 2
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Global Prevalence of Prediabetes
Rooney, M. R., Fang, M., Ogurtsova, K., Ozkan, B., Echouffo-Tcheugui, J. B., Boyko, E. J., Magliano, D. J., & Selvin, E. (2023) · Diabetes Care · doi:10.2337/dc22-2376 · Cited by 516
Diagnosis and Management of Prediabetes: A Review
Echouffo-Tcheugui, J. B., Perreault, L., Ji, L., & Dagogo-Jack, S. (2023) · JAMA · doi:10.1001/jama.2023.4063 · Cited by 473
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
Salazar de Pablo, G., Radua, J., Pereira, J., Bonoldi, I., Arienti, V., Besana, F., Soardo, L., Cabras, A., Fortea, L., Catalan, A., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0830 · Cited by 375
Schlesinger, S., Neuenschwander, M., Barbaresko, J., Lang, A., Maalmi, H., Rathmann, W., Roden, M., & Herder, C. (2022) · Diabetologia · doi:10.1007/s00125-021-05592-3 · Cited by 327
Metadata
- Authors
- Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-10-29
- Volume
- 2018
- Issue
- 11
- Pages
- CD012661-CD012661
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2898953814
- Cited by
- 283
- References
- 617
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.